'Optimistic' Pfizer chief won't rule out Astra break-up

Pfizer chief executive Ian Read is “optimistic” about gaining control of AstraZeneca, but won’t rule out breaking up the British drugmaker if his bid is successful.

“I never use the word hostile,” Read told the London Evening Standard amid expectations that a knock-out offer could be pitched direct to the British firm’s investors.

“We are talking to shareholders, we would like to talk to AstraZeneca… and we are still hopeful of an accommodation,” but meanwhile “we are considering all of our options, of course”.

Read, who today appeared before the Science and Technology Committee before touring City shareholders, said it was important for Viagra-maker Pfizer to win over politicians and the public because: “We want to be welcome in any country we are in. We don’t want to be fighting against society.”

He rejected claims that David Cameron had been cheerleading for his bid: “I believe the government is not supportive of either company, they are supportive of doing science in the UK.”

Read believes AstraZeneca boss Pascal Soriot “had a tough hand dealt” but had created “an interesting pipeline” of drugs.

He said, however: “You don’t transform your pipeline in 15 months. To build a pipeline you need five to six years. I think obviously there are interesting assets in AstraZeneca. I think they are far more interesting if they are combined with our portfolio.”

Read said his own shareholders “understand our position” but of course “they will not reward us if we overpay” for his prey.

US giant Pfizer has until May 26 to bid. Analysts believe the merged company could be carved up along product lines, as Kraft was following its controversial Cadbury takeover.

“I have not said I have got any intention of splitting this company up,” Read said, adding: “If at some point shareholders say to us, we don’t think you are running all of these businesses optimally and we think you could increase value by one of them being sold, well that is a possible option.”

Read told the select committee that Pfizer’s and AstraZeneca’s “science will continue” and  that the enlarged group would  be a world powerhouse in  cancer drugs.

For the second day running, Soriot faced MPs after Read  had been grilled by them. He warned that the group’s research work could “quickly lose momentum” because of the distraction of a merger.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

SThree: Talent Acquisition Consultant

£22500 - £27000 per annum + OTE £45K: SThree: Since our inception in 1986, STh...

Recruitment Genius: Experienced Financial Advisers and Paraplanners

Negotiable: Recruitment Genius: This extremely successful and well-established...

Guru Careers: FX Trader / Risk Manager

Competitive with monthly bonus: Guru Careers: We are seeking an experienced FX...

Day In a Page

Seifeddine Rezgui: What motivated a shy student to kill 38 holidaymakers in Tunisia?

Making of a killer

What motivated a shy student to kill 38 holidaymakers in Tunisia?
Ajmer: The ancient Indian metropolis chosen to be a 'smart city' where residents would just be happy to have power and running water

Residents just want water and power in a city chosen to be a ‘smart’ metropolis

The Indian Government has launched an ambitious plan to transform 100 of its crumbling cities
How to stop an asteroid hitting Earth: Would people co-operate to face down a global peril?

How to stop an asteroid hitting Earth

Would people cooperate to face a global peril?
Just one day to find €1.6bn: Greece edges nearer euro exit

One day to find €1.6bn

Greece is edging inexorably towards an exit from the euro
New 'Iron Man' augmented reality technology could help surgeons and firefighters, say scientists

'Iron Man' augmented reality technology could become reality

Holographic projections would provide extra information on objects in a person's visual field in real time
Sugary drinks 'are killing 184,000 adults around the world every year'

Sugary drinks are killing 184,000 adults around the world every year

The drinks that should be eliminated from people's diets
Pride of Place: Historians map out untold LGBT histories of locations throughout UK

Historians map out untold LGBT histories

Public are being asked to help improve the map
Lionel, Patti, Burt and The Who rock Glasto

Lionel, Patti, Burt and The Who rock Glasto

This was the year of 24-carat Golden Oldies
Paris Fashion Week

Paris Fashion Week

Thom Browne's scarecrows offer a rare beacon in commercial offerings
A year of the caliphate:

Isis, a year of the caliphate

Who can defeat the so-called 'Islamic State' – and how?
Marks and Spencer: Can a new team of designers put the spark back into the high-street brand?

Marks and Spencer

Can a new team of designers put the spark back into the high-street brand?
'We haven't invaded France': Italy's Prime Minister 'reclaims' Europe's highest peak

'We haven't invaded France'

Italy's Prime Minister 'reclaims' Europe's highest peak
Isis in Kobani: Why we ignore the worst of the massacres

Why do we ignore the worst of the massacres?

The West’s determination not to offend its Sunni allies helps Isis and puts us all at risk, says Patrick Cockburn
7/7 bombings 10 years on: Four emergency workers who saved lives recall the shocking day that 52 people were killed

Remembering 7/7 ten years on

Four emergency workers recall their memories of that day – and reveal how it's affected them ever since
Humans: Are the scientists developing robots in danger of replicating the hit Channel 4 drama?

They’re here to help

We want robots to do our drudge work, and to look enough like us for comfort. But are the scientists developing artificial intelligence in danger of replicating the TV drama Humans?